Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DWJ-1543 by Daewoong Pharmaceutical for Metastatic Breast Cancer: Likelihood of Approval
DWJ-1543 is under clinical development by Daewoong Pharmaceutical and currently in Phase I for Metastatic Breast Cancer. According to GlobalData,...
Data Insights
DWJ-1543 by Daewoong Pharmaceutical for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
DWJ-1543 is under clinical development by Daewoong Pharmaceutical and currently in Phase I for Human Epidermal Growth Factor Receptor 2...